Trials / Completed
CompletedNCT01935856
Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
A Dose Escalation, Single and Multiple Dose, Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate safety, pharmacokinetics and pharmacodynamics after single and multiple administration of KHK7580 for secondary hyperparathyroidism in patients receiving hemodialysis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KHK7580 | Oral administration |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2013-09-05
- Last updated
- 2017-03-03
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01935856. Inclusion in this directory is not an endorsement.